MedTrace Logo

Probiotics Against Low Grade Inflammation and Increased Intestinal Permeability in the Elderly

NCT02342496 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2018-04-17

No results posted yet for this study

Summary

The purpose of this study is to evaluate the ability of a blend of berries and probiotics in reducing low-grade inflammation and intestinal permeability in the elderly. The intervention period is one month. Blood and fecal samples will be collected for analysis at baseline and at the end of the intervention with the aim to analyse possible changes in different parameters at the two timepoints. The participants will also be asked to keep a study diary throughout the study period for the documentation of their intestinal health and as a means for checking compliance.

Conditions

  • Low-grade Inflammation
  • Increased Intestinal Permeability

Interventions

DIETARY_SUPPLEMENT

Placebo

Powder

DIETARY_SUPPLEMENT

Active, only probiotics

Powder

DIETARY_SUPPLEMENT

Active, blend of berries and probiotics

Powder

Sponsors & Collaborators

  • Lund University

    collaborator OTHER

  • Probi AB

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
75 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-12-31
Completion
2015-12-04

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02342496 on ClinicalTrials.gov